Growth Opportunity INDIGO has expanded its portfolio with metabolism-dependent safety screening and multiple receptor reporter assays, signaling a potential upsell of integrated screening services and expanded assay panels to existing drug discovery and safety clients.

Niche Leadership With a focus on cell-based luciferase reporter assays for nuclear receptors, GPCRs, cytokine and growth factor receptors, there is an opportunity to position INDIGO as a preferred partner for early lead identification and mechanism-of-action studies in niche receptor targets.

Geographic Reach Headquartered in State College, PA but serving labs worldwide, there is potential to expand regional services or co-marketing partnerships to enhance global access to custom assays and outsourcing options.

Full-Service Value Offering both ready-to-use reporter lines and contract assay services presents a cross-sell opportunity to convert customers who buy reagents into ongoing service partnerships for custom assays and project-based work.

Digital Engagement Current tech stack and online presence provide a foundation for targeted marketing automation and content campaigns around new assays (PrRPR/GPR10, GCGR, PrRPR, MC2R, insulin receptor, IGF-1R) to generate inbound interest and nurture high-LTV accounts.